NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3078% above fair value
$25.89−0.44 (-1.69%)
Close on Nov 17, 2026Market cap $572.57MP/E –Yield 2.01%
NRC Health cash
Cash and short-term investments held at the end of each period.
NRC Health's cash was $3.33M at Jun 30, 2026. For fiscal 2025 it was $4.14M, down 2.2% from the year before. Over ten years it grew -20.7% a year on average. The highest annual figure on record is $54.36M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.14M | -2.2% |
| FY2024 | Dec 31, 2024 | $4.23M | -36.4% |
| FY2023 | Dec 31, 2023 | $6.65M | -73.4% |
| FY2022 | Dec 31, 2022 | $25.03M | -54.0% |
| FY2021 | Dec 31, 2021 | $54.36M | +56.7% |
| FY2020 | Dec 31, 2020 | $34.69M | +156.6% |
| FY2019 | Dec 31, 2019 | $13.52M | +4.0% |
| FY2018 | Dec 31, 2018 | $12.99M | -62.6% |
| FY2017 | Dec 31, 2017 | $34.73M | +5.2% |
| FY2016 | Dec 31, 2016 | $33.02M | -21.6% |
| FY2015 | Dec 31, 2015 | $42.15M | +5.3% |
| FY2014 | Dec 31, 2014 | $40.04M | +81.3% |
| FY2013 | Dec 31, 2013 | $22.09M | +166.6% |
| FY2012 | Dec 31, 2012 | $8.29M | +2.5% |
| FY2011 | Dec 31, 2011 | $8.08M | +129.7% |
| FY2010 | Dec 31, 2010 | $3.52M | +40.1% |
| FY2009 | Dec 31, 2009 | $2.51M | +126.5% |
| FY2008 | Dec 31, 2008 | $1.11M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.33M | -36.9% |
| Q1 FY2026 | Mar 31, 2026 | $2.55M | +1.8% |
| Q4 FY2025 | Dec 31, 2025 | $4.14M | -2.2% |
| Q3 FY2025 | Sep 30, 2025 | $2.22M | -35.9% |
| Q2 FY2025 | Jun 30, 2025 | $5.27M | +987.4% |
| Q1 FY2025 | Mar 31, 2025 | $2.50M | +47.3% |
| Q4 FY2024 | Dec 31, 2024 | $4.23M | -36.4% |
| Q3 FY2024 | Sep 30, 2024 | $3.46M | -9.6% |
| Q2 FY2024 | Jun 30, 2024 | $485.00K | -97.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.70M | -92.8% |
| Q4 FY2023 | Dec 31, 2023 | $6.65M | -73.4% |
| Q3 FY2023 | Sep 30, 2023 | $3.83M | -86.5% |
| Q2 FY2023 | Jun 30, 2023 | $22.50M | -31.8% |
| Q1 FY2023 | Mar 31, 2023 | $23.72M | -49.8% |
| Q4 FY2022 | Dec 31, 2022 | $25.03M | -54.0% |
| Q3 FY2022 | Sep 30, 2022 | $28.39M | -45.9% |
| Q2 FY2022 | Jun 30, 2022 | $32.97M | -32.6% |
| Q1 FY2022 | Mar 31, 2022 | $47.29M | +8.8% |
| Q4 FY2021 | Dec 31, 2021 | $54.36M | +56.7% |
| Q3 FY2021 | Sep 30, 2021 | $52.48M | +140.1% |
| Q2 FY2021 | Jun 30, 2021 | $48.90M | +309.0% |
| Q1 FY2021 | Mar 31, 2021 | $43.45M | +333.6% |
| Q4 FY2020 | Dec 31, 2020 | $34.69M | +156.6% |
| Q3 FY2020 | Sep 30, 2020 | $21.86M | +161.5% |
| Q2 FY2020 | Jun 30, 2020 | $11.96M | +197.4% |
| Q1 FY2020 | Mar 31, 2020 | $10.02M | +279.4% |
| Q4 FY2019 | Dec 31, 2019 | $13.52M | +4.0% |
| Q3 FY2019 | Sep 30, 2019 | $8.36M | +14.9% |
| Q2 FY2019 | Jun 30, 2019 | $4.02M | -40.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.64M | -92.6% |
| Q4 FY2018 | Dec 31, 2018 | $12.99M | -62.6% |
| Q3 FY2018 | Sep 30, 2018 | $7.27M | -79.7% |
| Q2 FY2018 | Jun 30, 2018 | $6.70M | -78.8% |
| Q1 FY2018 | Mar 31, 2018 | $35.48M | +2.3% |
| Q4 FY2017 | Dec 31, 2017 | $34.73M | +5.2% |
| Q3 FY2017 | Sep 30, 2017 | $35.75M | +23.8% |
| Q2 FY2017 | Jun 30, 2017 | $31.63M | – |
| Q1 FY2017 | Mar 31, 2017 | $34.66M | – |
| Q4 FY2016 | Dec 31, 2016 | $33.02M | – |
| Q3 FY2016 | Sep 30, 2016 | $28.88M | – |
See a number that looks wrong?